Bevacizumab in addition to cisplatin and irinotecan is active as treatment for gastric cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1566, 2006-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluorouracil + folinic acid + cisplatin active in gastric cancer

Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Concurrent treatment with epirubicin, docetaxel and cisplatin shows activity in metastatic gastric cancer

Inpharma, Vol. 1, Iss. 1448, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Treatment with irinotecan plus cisplatin has a similar survival benefit to etoposide plus cisplatin in patients with extensive-stage small cell lung cancer

Inpharma, Vol. 1, Iss. 1540, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Cisplatin + epirubicin is active in the treatment of metastatic germ cell cancer

Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Docetaxel plus cisplatin: active and well tolerated in locally advanced or metastatic gastric cancer

Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite